Mobile App Click here to download our Mobile App for iOS or Android
Not a member? Sign up for free!

Why Value-Based Purchasing For Medications Matters

News | September 7, 2020

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

The Centers for Medicare and Medicaid Services (CMS) made big news once again. On June 17, CMS issued a proposed rule to grant state Medicaid programs and other payers flexibility to enter value-based payment (VBP) arrangements with drug manufacturers. The rule’s definition of VBP is an arrangement intended to align payments to therapeutic or clinical…

You must be logged in to read the full article: Join PsychU or Log In

Now Leaving PsychU

This link will take you outside of the PsychU community website.

By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.

Continue to link outside of PsychU Remain on PsychU website
×

Now Leaving PsychU

This link will take you to a website outside of PsychU.org.

Continue To External Website Remain On PsychU.org
×

You are attempting to log out of PsychU, please confirm.

Log Out Return
×